News

xFOREST Therapeutics Achieves A Milestone in Drug Discovery Collaboration with Takeda.

xFOREST Therapeutics (Headquarter: Sakyo-ku, Kyoto, Japan; President and CEO: Shunichi Kashida; hereinafter, xFOREST) is pleased to announce the achievement of a milestone as part of drug discovery collaboration with Takeda to target RNA structures in neurological diseases. This project was initiated on September 25, 2020. As a result of this achievement, xFOREST will receive a milestone payment.